Authors: RIZZO JA SIMONS WR

Citation: Ja. Rizzo et Wr. Simons, VARIATIONS IN COMPLIANCE AMONG HYPERTENSIVE PATIENTS BY DRUG CLASS - IMPLICATIONS FOR HEALTH-CARE COSTS, Clinical therapeutics, 19(6), 1997, pp. 1446-1457

Authors: SIMONS WR HAIM M RIZZO J ZANNAD F

Citation: Wr. Simons et al., EFFECT OF IMPROVED DISEASE MANAGEMENT STRATEGIES ON HOSPITAL LENGTH OF STAY IN THE TREATMENT OF CONGESTIVE-HEART-FAILURE, Clinical therapeutics, 18(4), 1996, pp. 726-746

Authors: SIMONS WR

Citation: Wr. Simons, THE COSTS AND EFFECTS OF SWITCHING CALCIUM-CHANNEL BLOCKERS - EVIDENCE FROM MEDICAID CLAIMS DATA (VOL 17, PG 154, 1995), Clinical therapeutics, 17(2), 1995, pp. 348-351

Authors: SIMONS WR RIZZO JA STODDARD M SMITH ME

Citation: Wr. Simons et al., THE COSTS AND EFFECTS OF SWITCHING CALCIUM-CHANNEL BLOCKERS - EVIDENCE FROM MEDICAID CLAIMS DATA, Clinical therapeutics, 17(1), 1995, pp. 154-173

Authors: SIMONS WR SMITH ME

Citation: Wr. Simons et Me. Smith, HEALTH ECONOMICS AND OUTCOMES RESEARCH WITH RETROSPECTIVE DATA, Clinical therapeutics, 16(6), 1994, pp. 1063-1067

Authors: PASHKO S SIMONS WR SENA MM STODDARD ML

Citation: S. Pashko et al., RATE OF EXPOSURE TO THEOPHYLLINE DRUG-INTERACTIONS, Clinical therapeutics, 16(6), 1994, pp. 1068-1077